Risk factors for recurrence in patients with Clostridium difficile infection due to 027 and non-027 ribotypes

Autor: Maurizio Sanguinetti, Paolo Carfagna, Marco Falcone, Carla Fontana, Massimo Andreoni, Paola Goldoni, Claudio Maria Mastroianni, Nicola Petrosillo, R. Murri, F. Iraci, Giusy Tiseo, Iolanda Santino, Mario Venditti, Massimo Fantoni, Roberto Cauda, Alessio Farcomeni, D. Delle Rose, Guido Antonelli, Giammarco Raponi, Antonio Aceti

Our objective was to evaluate factors associated with recurrence in patients with 027+ and 027- Clostridium difficile infection (CDI).Patients with CDI observed between January and December 2014 in six hospitals were consecutively included in the stu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9356e460f56ceb1148c08ec874ea571e
http://hdl.handle.net/2108/205574

Raltegravir Plasma Concentrations in Treatment-Experienced Patients Receiving Salvage Regimens Based on Raltegravir with and without Maraviroc Coadministration

Autor: Silvia Baroncelli, Paola Villani, Liliana E. Weimer, Nicoletta Ladisa, Daniela Francisci, Chiara Tommasi, Vincenzo Vullo, Roberta Preziosi, Stefania Cicalini, Maria Cusato, Clementina M. Galluzzo, Marco Floridia, Mario Regazzi, for the ISS NIA Group […, R. Bucciardini, M. Floridia, LE Weimer, V. Fragola, M. Massella, S. Baroncelli, CM Galluzzo, MF Pirillo, MG Mancini, R. Amici, A. Cara, R. Bona, P. Leone, P. Filati, M. Franco, S. Donnini, M. Mirra, M. Di Gregorio, S. Lucattini, L. Fucili, F. Baldelli, D. Francisci, L. Martinelli, G. Masini, S. Bastianelli, G. Angarano, N. Ladisa, A. Volpe, V. Vullo, G. D’Ettorre, G. Ceccarelli, M. Andreoni, L. Sarmati, D. Delle Rose, M. Montano, V. Tozzi, R. Libertone, L. Pucillo, P. Narciso, R. Bellagamba, C. Tommasi, N. Petrosillo, S. Cicalini, F. Ghinelli, L. Sighinolfi, D. Segala, O. Armignacco, R. Preziosi, C. Ferrari, A. Degli Antoni, A. Cavalli, G. Parruti, F. Sozio, L. Cosentino, D. Dionisio, A. Vivarelli, PE Manconi, F. Ortu, ML Di Martino, R. Motta, R. Del Gobbo, A. Mataloni Paggi, C. Silvestri, G. Scalise, A. Giacometti, O. Cirioni, S. Sebastianelli, E. Marchionni, E. Gabrielli, MS Mura, M. Mannazzu, G. Cattari, G. Coinu, G. Guaraldi, B. Beghetto, G. Nardini, VIALE, PIERLUIGI, VERUCCHI, GABRIELLA, BORDERI, MARCO, PIERGENTILI, BENEDETTA

Publikováno v: Annals of Pharmacotherapy. 44:838-843

BACKGROUND: Raltegravir and maraviroc represent new, important resources for HIV-infected patients with intolerance or resistance to other antiretroviral agents. The safety and efficacy of both drugs have been investigated, but there is no informatio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bb2e87cc2268a611143d40299c84ad6
https://doi.org/10.1345/aph.1m688

Dapsone hypersensitivity syndrome complicated by Scedosporium apiospermum pneumonia in an immunocompetent patient

Autor: Laura Ceccarelli, Massimo Andreoni, Loredana Sarmati, D. Delle Rose, Pasquale Sordillo, G. Calisti, A. Ricciardi, Gaetano Maffongelli

Publikováno v: Infection. 40:459-462

Dapsone (4,40diaminodiphenyl sulphone) has been used since the middle of the 20th century for leprosy treatment, usually in combination with rifampin and clofazimine. Dapsone hypersensitivity syndrome (DHS) occurs in 0.5-3% of patients treated with t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee6bafd6bddfd3c0fe2b7c724a8ba43f
https://doi.org/10.1007/s15010-011-0225-2

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.